Delivery Order SPE2DR25D9367-SPE2DR26FKKR2
Award Date 2/9/26
Potential Completion Date 2/10/26
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, for $2,493.75 to supply Fasenra (reslizumab) 30 mg/mL under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $29,925.00, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Fasenra 30 mg/ml syringe. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to...
- The Defense Logistics Agency issued a $6,142.92 delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for FASENRA pen 30 mg/ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a ceiling of $499,999,999. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. Place of performance is Park Ridge, IL. The order is firm fixed price with...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for $73,715.04 (ceiling value) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of FASENRA PEN 30 MG/ML. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceuticals, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide....
- The Defense Logistics Agency awarded a $13,167 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award was issued on January 22, 2026, with an ultimate completion date of January 23, 2026, under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, IL location. This delivery order represents...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA Pen 30 mg/mL. The delivery order, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $39,900 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra 30 mg/mL syringes. The award, issued on December 17, 2025, with a completion date of December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. This contract leverages DMS Pharmaceutical Group's position as a regional prime vendor under the DLA's Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,975.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. The award, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, indicating the contractor competed on an unrestricted basis. This delivery order is issued under DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 9, 2026, with a ceiling value of $12,285.84 for supply of Fasenra (reslizumab) 30 mg/mL. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a DLA indefinite delivery contract that authorizes firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, biologics, and medical consumables to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,975 on February 3, 2026, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of FASENRA Pen 30 mg/ml. This firm fixed-price delivery order carries an ultimate completion date of February 4, 2026, and was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement....